Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Tatiana Bremova-Ertl & Susanne Schneider. (2023) Current advancements in therapy for Niemann-Pick disease: progress and pitfalls. Expert Opinion on Pharmacotherapy 24:11, pages 1229-1247.
Read now
Read now
Stephanie CM Nijmeijer & Frits A Wijburg. (2018) Mucopolysaccharidosis type III: current clinical trials, challenges and recommendations. Expert Opinion on Orphan Drugs 6:1, pages 9-15.
Read now
Read now
Vincenzo Di Lazzaro, Massimo Marano, Lucia Florio & Stefano De Santis. (2016) Niemann–Pick type C: focus on the adolescent/adult onset form. International Journal of Neuroscience 126:11, pages 963-971.
Read now
Read now
Giancarlo Parenti, Marco Moracci, Simona Fecarotta & Generoso Andria. (2014) Pharmacological Chaperone Therapy for Lysosomal Storage Diseases. Future Medicinal Chemistry 6:9, pages 1031-1045.
Read now
Read now
Sawa Ito & A. John Barrett. (2013) Response to the Letter: Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease. Pediatric Hematology and Oncology 30:5, pages 462-463.
Read now
Read now
Maciej Machaczka, Robert Hast, Ingrid Dahlman, Richard Lerner, Monika Klimkowska, Martin Engvall & Hans Hägglund. (2012) Substrate reduction therapy with miglustat for type 1 Gaucher disease: A retrospective analysis from a single institution. Upsala Journal of Medical Sciences 117:1, pages 28-34.
Read now
Read now
Juan M Benito, José M García Fernández & Carmen Ortiz Mellet. (2011) Pharmacological chaperone therapy for Gaucher disease: a patent review. Expert Opinion on Therapeutic Patents 21:6, pages 885-903.
Read now
Read now
BE Smid, JMFG Aerts, RG Boot, GE Linthorst & CEM Hollak. (2010) Pharmacological small molecules for the treatment of lysosomal storage disorders. Expert Opinion on Investigational Drugs 19:11, pages 1367-1379.
Read now
Read now
James E Wraith & Jackie Imrie. (2009) New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat. Therapeutics and Clinical Risk Management 5, pages 877-887.
Read now
Read now
Jackie Imrie, Carmen Galani, Kerry Gairy, Kevin Lock & Elke Hunsche. (2009) Cost of illness associated with Niemann-Pick disease type C in the UK. Journal of Medical Economics 12:3, pages 219-229.
Read now
Read now
Gregory M. Pastores, Pilar Giraldo, Patrick Chérin & Atul Mehta. (2009) Goal-oriented therapy with miglustat in Gaucher disease. Current Medical Research and Opinion 25:1, pages 23-37.
Read now
Read now
Kiyotaka NAKAGAWA, Hiroyuki KUBOTA, Tsuyoshi TSUZUKI, Jun KARIYA, Toshiyuki KIMURA, Shinichi OIKAWA & Teruo MIYAZAWA. (2008) Validation of an Ion Trap Tandem Mass Spectrometric Analysis of Mulberry 1-Deoxynojirimycin in Human Plasma: Application to Pharmacokinetic Studies. Bioscience, Biotechnology, and Biochemistry 72:8, pages 2210-2213.
Read now
Read now
Aarnoud C van der Spoel, Richard Mott & Frances M Platt. (2008) Differential Sensitivity of Mouse Strains to an N-Alkylated Imino Sugar: Glycosphingolipid Metabolism and Acrosome Formation. Pharmacogenomics 9:6, pages 717-731.
Read now
Read now
Articles from other publishers (62)
Akhil Kulkarni, Tiffany Chen, Ellen Sidransky & Tae-Un Han. (2024) Advancements in Viral Gene Therapy for Gaucher Disease. Genes 15:3, pages 364.
Crossref
Crossref
Vahid Mansouri, Ali Reza Tavasoli, Masoud Khodarahmi, Mohammad Sedigh Dakkali, Sara Daneshfar, Mahmoud Reza Ashrafi, Morteza Heidari, Sareh Hosseinpour, Fariborz Sharifianjazi & Maryam Bemanalizadeh. (2023)
Efficacy and safety of miglustat in the treatment of
GM2
gangliosidosis: A systematic review
. European Journal of Neurology 30:9, pages 2919-2945.
Crossref
Crossref
Khalifa El Malki, Pia Wehling, Francesca Alt, Roger Sandhoff, Sebastian Zahnreich, Arsenij Ustjanzew, Carolin Wilzius, Marc A. Brockmann, Arthur Wingerter, Alexandra Russo, Olaf Beck, Clemens Sommer, Malte Ottenhausen, Katrin B. M. Frauenknecht, Claudia Paret & Jörg Faber. (2023) Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation. International Journal of Molecular Sciences 24:12, pages 9905.
Crossref
Crossref
Rebecca Mächtel, Fanni Annamária Boros, Jan Philipp Dobert, Philipp Arnold & Friederike Zunke. (2023) From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities. Journal of Molecular Biology 435:12, pages 167932.
Crossref
Crossref
Veronica Antipova, Lisa-Marie Steinhoff, Carsten Holzmann, Arndt Rolfs, Carlos Junior Hempel, Martin Witt & Andreas Wree. (2022) Organ Weights in NPC1 Mutant Mice Partly Normalized by Various Pharmacological Treatment Approaches. International Journal of Molecular Sciences 24:1, pages 573.
Crossref
Crossref
Aimee Donald, Cecilia Kämpe Björkvall, Ashok Vellodi, Timothy M. Cox, Derralyn Hughes, Simon A. Jones, Robert Wynn & Maciej Machaczka. (2022) Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Laura López de Frutos, Francisco Almeida, Jessica Murillo-Saich, Vasco A. Conceição, Monica Guma, Oswald Queheberger, Pilar Giraldo & Gabriel Miltenberger-Miltenyi. (2022) Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson’s Disease. International Journal of Molecular Sciences 23:18, pages 10387.
Crossref
Crossref
Merve Koç Yekedüz, Ümmühan Öncül, Engin Köse & Fatma Tuba Eminoğlu. (2022) Probable Miglustat-Induced Psychosis in a Child With Niemann-Pick Type C. Clinical Neuropharmacology 45:4, pages 107-109.
Crossref
Crossref
William M. Pardridge. (2022) Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins. Advanced Drug Delivery Reviews 184, pages 114234.
Crossref
Crossref
Konstantin Senkevich, Uladzislau Rudakou & Ziv Gan-Or. (2022) New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin. Neuropharmacology 202, pages 108822.
Crossref
Crossref
Florina Zakany, Tamas Kovacs, Lajos Szente & Zoltan Varga. 2022. Cholesterol. Cholesterol
927
967
.
Takahiro Fujii, Yuta Tanaka, Hideyuki Oki, Sho Sato, Sachio Shibata, Takamitsu Maru, Yuta Tanaka, Maiko Tanaka & Tomohiro Onishi. (2021) A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease. Journal of Neurochemistry 159:3, pages 543-553.
Crossref
Crossref
Elena-Raluca Nicoli, Ida Annunziata, Alessandra d’Azzo, Frances M. Platt, Cynthia J. Tifft & Karolina M. Stepien. (2021) GM1 Gangliosidosis—A Mini-Review. Frontiers in Genetics 12.
Crossref
Crossref
Carsten Holzmann, Martin Witt, Arndt Rolfs, Veronica Antipova & Andreas Wree. (2021) Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1. International Journal of Molecular Sciences 22:5, pages 2539.
Crossref
Crossref
Arthur Wingerter, Khalifa El Malki, Roger Sandhoff, Larissa Seidmann, Daniel-Christoph Wagner, Nadine Lehmann, Nadine Vewinger, Katrin B. M. Frauenknecht, Clemens J. Sommer, Frank Traub, Thomas Kindler, Alexandra Russo, Henrike Otto, André Lollert, Gundula Staatz, Lea Roth, Claudia Paret & Jörg Faber. (2021) Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma. Cancers 13:3, pages 520.
Crossref
Crossref
Dario Carradori, Hsintsung Chen, Beat Werner, Aagam S. Shah, Chiara Leonardi, Mattia Usuelli, Raffaele Mezzenga, Frances Platt & Jean‐Christophe Leroux. (2020) Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann‐Pick Disease Type C Using Crosslinked 2‐Hydroxypropyl‐β‐cyclodextrin. Small 16:46.
Crossref
Crossref
Rita Fischetto, Valentina Palladino, Maria M. Mancardi, Thea Giacomini, Stefano Palladino, Alberto Gaeta, Maja Di Rocco, Lucia Zampini, Giuseppe Lassandro, Vito Favia, Maria E. Tripaldi, Pietro Strisciuglio, Alfonso Romano, Mariasavina Severino, Amelia Morrone & Paola Giordano. (2020) Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience. Molecular Genetics & Genomic Medicine 8:10.
Crossref
Crossref
Anne Gläser, Franziska Hammerl, Markus H. Gräler, Sina M. Coldewey, Christin Völkner, Moritz J. Frech, Fan Yang, Jiankai Luo, Eric Tönnies, Oliver von Bohlen und Halbach, Nicola Brandt, Diana Heimes, Anna-Maria Neßlauer, Georg Christoph Korenke, Marta Owczarek-Lipska, John Neidhardt, Arndt Rolfs, Andreas Wree, Martin Witt & Anja Ursula Bräuer. (2020) Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate Metabolism. International Journal of Molecular Sciences 21:12, pages 4502.
Crossref
Crossref
Vijayalaxmi Gupta, Sheri A. Hild, Sudhakar R. Jakkaraj, Erick J. Carlson, Henry L. Wong, C. Leigh Allen, Gunda I. Georg & Joseph S. Tash. (2019) N-Butyldeoxygalactonojirimycin Induces Reversible Infertility in Male CD Rats. International Journal of Molecular Sciences 21:1, pages 301.
Crossref
Crossref
Kusum Yadav, Anurag Yadav, Priyanka Vashistha, Veda P. Pandey & Upendra N. Dwivedi. (2019) Protein Misfolding Diseases and Therapeutic Approaches. Current Protein & Peptide Science 20:12, pages 1226-1245.
Crossref
Crossref
Jonathan Cramer, Christoph P. Sager & Beat Ernst. (2019) Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group. Journal of Medicinal Chemistry 62:20, pages 8915-8930.
Crossref
Crossref
Natalie Hammond, Andrew B. Munkacsi & Stephen L. Sturley. (2019) The complexity of a monogenic neurodegenerative disease: More than two decades of therapeutic driven research into Niemann-Pick type C disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1864:8, pages 1109-1123.
Crossref
Crossref
Hui Zhao & Wei Zhao. (2019) Development of a high resolution mass spectrometry method for the determination of danshensu and salvianolic acid B. SN Applied Sciences 1:5.
Crossref
Crossref
Dominick Amato & Mary Anne Patterson. (2018) Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports. Journal of Medical Case Reports 12:1.
Crossref
Crossref
Mercè Pineda, Mark Walterfang & Marc C. Patterson. (2018) Miglustat in Niemann-Pick disease type C patients: a review. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Pilar Giraldo, Marcio Andrade-Campos, Pilar Alfonso, Pilar Irun, Koldo Atutxa, Antonio Acedo, Abelardo Barez, Margarita Blanes, Vicente Diaz-Morant, Ma Angeles Fernández-Galán, Rafael Franco, Cristina Gil-Cortes, Vicente Giner, Angela Ibañez, Paz Latre, Ines Loyola, Elisa Luño, Roberto Hernández-Martin, Blanca Medrano-Engay, José Puerta, Inmaculada Roig, Javier de la Serna, Olga Salamero, Lucia Villalón & Miguel Pocovi. (2018) Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project. Blood Cells, Molecules, and Diseases 68, pages 173-179.
Crossref
Crossref
J. L. Kiappes, Michelle L. HillDominic S. AlonziJoanna L. MillerRen Iwaki, Andrew C. SayceAlessandro T. CaputoAtsushi Kato & Nicole Zitzmann. (2017) ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity. ACS Chemical Biology 13:1, pages 60-65.
Crossref
Crossref
Ferdinando Ceravolo, Michele Grisolia, Simona Sestito, Francesca Falvo, Maria Teresa Moricca & Daniela Concolino. (2017) Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report. Journal of Medical Case Reports 11:1.
Crossref
Crossref
N. Guérard, O. Morand & J. Dingemanse. (2017) Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects. Orphanet Journal of Rare Diseases 12:1.
Crossref
Crossref
Federica Deodato, Elena Procopio, Angelica Rampazzo, Roberta Taurisano, Maria Alice Donati, Carlo Dionisi-Vici, Anna Caciotti, Amelia Morrone & Maurizio Scarpa. (2017) The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression. Metabolic Brain Disease 32:5, pages 1529-1536.
Crossref
Crossref
Jeanine R. Jarnes Utz, Sarah Kim, Kelly King, Richard Ziegler, Lynn Schema, Evelyn S. Redtree & Chester B. Whitley. (2017) Infantile gangliosidoses: Mapping a timeline of clinical changes. Molecular Genetics and Metabolism 121:2, pages 170-179.
Crossref
Crossref
Gaetano Giuffrida, Rita Lombardo, Ernesto Di Francesco, Laura Parrinello, Francesco Di Raimondo & Agata Fiumara. (2016) Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report. Journal of Medical Case Reports 10:1.
Crossref
Crossref
Victoria Schlegel, Markus Thieme, Carsten Holzmann, Martin Witt, Ulrike Grittner, Arndt Rolfs & Andreas Wree. (2016) Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice. International Journal of Molecular Sciences 17:11, pages 1866.
Crossref
Crossref
Samantha J. Spratley & Janet E. Deane. (2016) New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones. Journal of Neuroscience Research 94:11, pages 1203-1219.
Crossref
Crossref
Jeanine Utz, Chester B. Whitley, Paul L.M. van Giersbergen & Stefan A. Kolb. (2016) Comorbidities and pharmacotherapies in patients with Gaucher disease type 1: The potential for drug–drug interactions. Molecular Genetics and Metabolism 117:2, pages 172-178.
Crossref
Crossref
Fay Probert, Victor Ruiz-Rodado, Xiaoyu Zhang, Danielle te Vruchte, Tim D.W. Claridge, Mark Edgar, Anna Zonato Tocchio, Robin H. Lachmann, Frances M. Platt & Martin Grootveld. (2016) Urinary excretion and metabolism of miglustat and valproate in patients with Niemann–Pick type C1 disease: One- and two-dimensional solution-state 1 H NMR studies. Journal of Pharmaceutical and Biomedical Analysis 117, pages 276-288.
Crossref
Crossref
Magalí C. Girard, Flavia Sacerdoti, Fulton P. Rivera, Horacio A. Repetto, Cristina Ibarra & María M. Amaral. (2015) Prevention of renal damage caused by Shiga toxin type 2: Action of Miglustat on human endothelial and epithelial cells. Toxicon 105, pages 27-33.
Crossref
Crossref
Maurizio Scarpa, Cinzia Maria Bellettato, Christina Lampe & David J. Begley. (2015) Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system. Best Practice & Research Clinical Endocrinology & Metabolism 29:2, pages 159-171.
Crossref
Crossref
Chris H. Hill, Agnete H. Viuff, Samantha J. Spratley, Stéphane Salamone, Stig H. Christensen, Randy J. Read, Nigel W. Moriarty, Henrik H. Jensen & Janet E. Deane. (2015) Azasugar inhibitors as pharmacological chaperones for Krabbe disease. Chemical Science 6:5, pages 3075-3086.
Crossref
Crossref
Edmund Sybertz & Dimitri Krainc. (2014) Development of targeted therapies for Parkinson's disease and related synucleinopathies. Journal of Lipid Research 55:10, pages 1996-2003.
Crossref
Crossref
Carole Le Henaff, Eric Haÿ, Frédéric Velard, Caroline Marty, Olivier Tabary, Pierre J. Marie & Jacky P. Jacquot. (2014) Enhanced F508del-CFTR Channel Activity Ameliorates Bone Pathology in Murine Cystic Fibrosis. The American Journal of Pathology 184:4, pages 1132-1141.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2013) Miglustat: A Review of Its Use in Niemann-Pick Disease Type C. Drugs 74:1, pages 61-74.
Crossref
Crossref
Jianfeng Wang, Lishuang Liang, Qiongyu Zhang, Xingang Li & Zhijian Fu. (2013) Preclinical pharmacokinetics, tissue distribution and excretion studies of a potential analgesics – corydaline using an ultra performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 942-943, pages 70-76.
Crossref
Crossref
Changchuan Guo, Yan Jiang, Li Li, Lan Hong, Yuqing Wang, Qian Shen, Yan Lou, Haihong Hu, Hui Zhou, Lushan Yu, Huidi Jiang & Su Zeng. (2013) Application of a liquid chromatography–tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of Dactylicapnos scandens in rats. Journal of Pharmaceutical and Biomedical Analysis 74, pages 92-100.
Crossref
Crossref
Robert J. Desnick, Edward H. Schuchman, Kenneth H. Astrin & Seng H. Cheng. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics
1
30
.
Mahdi Amiri & Hassan Y. Naim. (2012) Miglustat‐induced intestinal carbohydrate malabsorption is due to the inhibition of α‐glucosidases, but not β‐galactosidases. Journal of Inherited Metabolic Disease 35:6, pages 949-954.
Crossref
Crossref
Marc C. Patterson, Christian J. Hendriksz, Mark Walterfang, Frederic Sedel, Marie T. Vanier & Frits Wijburg. (2012) Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update. Molecular Genetics and Metabolism 106:3, pages 330-344.
Crossref
Crossref
Elke Spieker, Winfried Wagner-Redeker & Jasper Dingemanse. (2012) Validated LC–MS/MS method for the quantitative determination of the glucosylceramide synthase inhibitor miglustat in mouse plasma and human plasma and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 59, pages 123-129.
Crossref
Crossref
Nathalie Guffon, Sylvie Bin-Dorel, Evelyne Decullier, Carole Paillet, Jérôme Guitton & Alain Fouilhoux. (2011) Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Pediatrics 159:5, pages 838-844.e1.
Crossref
Crossref
Maria Cristina Dechecchi, Elena Nicolis, Paola Mazzi, Federica Cioffi, Valentino Bezzerri, Ilaria Lampronti, Song Huang, Ludovic Wiszniewski, Roberto Gambari, Maria Teresa Scupoli, Giorgio Berton & Giulio Cabrini. (2011) Modulators of Sphingolipid Metabolism Reduce Lung Inflammation. American Journal of Respiratory Cell and Molecular Biology 45:4, pages 825-833.
Crossref
Crossref
Christine A. Denny, Karie A. Heinecke, Youngho P. Kim, Rena C. Baek, Katrina S. Loh, Terry D. Butters, Roderick T. Bronson, Frances M. Platt & Thomas N. Seyfried. (2010)
Restricted ketogenic diet enhances the therapeutic action of
N
‐butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice
. Journal of Neurochemistry 113:6, pages 1525-1535.
Crossref
Crossref
James E. Wraith, Darleen Vecchio, Elizabeth Jacklin, Larry Abel, Harbajan Chadha-Boreham, Cécile Luzy, Ruben Giorgino & Marc C. Patterson. (2010) Miglustat in adult and juvenile patients with Niemann–Pick disease type C: Long-term data from a clinical trial. Molecular Genetics and Metabolism 99:4, pages 351-357.
Crossref
Crossref
C. M. E. Tallaksen & J. E. Berg. (2009) Miglustat therapy in juvenile Sandhoff disease. Journal of Inherited Metabolic Disease 32:S1, pages 289-293.
Crossref
Crossref
Caroline Norez, Fabrice Antigny, Sabrina Noel, Clarisse Vandebrouck & Frédéric Becq. (2009) A Cystic Fibrosis Respiratory Epithelial Cell Chronically Treated by Miglustat Acquires a Non–Cystic Fibrosis–Like Phenotype. American Journal of Respiratory Cell and Molecular Biology 41:2, pages 217-225.
Crossref
Crossref
Giancarlo Parenti. (2009) Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. EMBO Molecular Medicine 1:5, pages 268-279.
Crossref
Crossref
Caterina Porto, Monica Cardone, Federica Fontana, Barbara Rossi, Maria Rosaria Tuzzi, Antonietta Tarallo, Maria Vittoria Barone, Generoso Andria & Giancarlo Parenti. (2009) The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts. Molecular Therapy 17:6, pages 964-971.
Crossref
Crossref
M. L. F. Santos, S. Raskin, D. S. Telles, A. Löhr Junior, P. B. N. Liberalesso, S. C. Vieira & M. L. Cordeiro. (2008) Treatment of a child diagnosed with Niemann–Pick disease type C with miglustat: A case report in Brazil. Journal of Inherited Metabolic Disease 31:S2, pages 357-361.
Crossref
Crossref
Maria Cristina Dechecchi, Elena Nicolis, Caroline Norez, Valentino Bezzerri, Monica Borgatti, Irene Mancini, Paolo Rizzotti, Carla M.P. Ribeiro, Roberto Gambari, Frederic Becq & Giulio Cabrini. (2008) Anti-inflammatory effect of miglustat in bronchial epithelial cells. Journal of Cystic Fibrosis 7:6, pages 555-565.
Crossref
Crossref
Raphael Schiffmann, Edmond J. FitzGibbon, Chris Harris, Catherine DeVile, Elin H. Davies, Larry Abel, Ivo N. Van Schaik, William S. Benko, Margaret Timmons, Markus Ries & Ashok Vellodi. (2008) Randomized, controlled trial of miglustat in Gaucher's disease type 3. Annals of Neurology 64:5, pages 514-522.
Crossref
Crossref
Elena Elliot-Smith, Anneliese O. Speak, Emyr Lloyd-Evans, David A. Smith, Aarnoud C. van der Spoel, Mylvaganam Jeyakumar, Terry D. Butters, Raymond A. Dwek, Alessandra d’Azzo & Frances M. Platt. (2008) Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis. Molecular Genetics and Metabolism 94:2, pages 204-211.
Crossref
Crossref
Marc C Patterson, Darleen Vecchio, Helena Prady, Larry Abel & James E Wraith. (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. The Lancet Neurology 6:9, pages 765-772.
Crossref
Crossref
Gregory M. Pastores, Deborah Elstein, Martin Hrebícek & Ari Zimran. (2007) Effect of Miglustat on Bone Disease in Adults with Type 1 Gaucher Disease: A Pooled Analysis of Three Multinational, Open-Label Studies. Clinical Therapeutics 29:8, pages 1645-1654.
Crossref
Crossref